The approval of new prescription-free glucose biosensors has significantly broadened access to continuous glucose monitoring (CGM) technology for various populations, including those with prediabetes and...
Laura Davisson, MD, MPH, FACP, professor of medicine, West Virginia University, discusses the rapidly evolving pharmacologic landscape for obesity management, including practical strategies for handling...
In this video, Karlijn Burridge, PA-C, MMS, FOMA, provides a preview of her session "Digging Deeper: Comprehensive Obesity Care” at our Practical Updates in Primary Care 2024 Virtual. She gives an overview...
In this video, Anum Minhas, MD, MHS, discusses the potential cardiovascular risks of estrogens and progestins, the contraceptive recommendation for patients seeking to avoid pregnancy and have a high risk...
In this video, James Matera, DO moderates a roundtable discussion with Colin Brown, MD, Kunal Gupta MD, and Lisa Jones, MA, RD that reviews the recent developments regarding the treatment and management of...
In this video, Karlijn Burridge, PA-C, MMS, FOMA, talks about her session at our Practical Updates in Primary Care 2024 Virtual Series. Karlijn Burridge talks about how clinicians can work together with...
In this video, Angela Golden, DNP, FNP-C, discusses evidence-based approaches in the management of patients with obesity, including the use of medications, surgery, and controversies.
In this video, Anum Minhas, MD, MHS, discusses recommendations for contraceptives in women with heart disease, obesity, high blood pressure, or diabetes in a cardiology setting, including dependable...
In this video, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, speaks about the use of glucagon-like peptide-1 (GLP-1s) agonists in patients with type 2 diabetes (T2D) and obesity, including how the medication...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
